Robert L. Jones

Robert L. Jones has a broad corporate law practice devoted to the representation of technology companies, and particularly companies in the life sciences industries. His practice includes the full range of corporate and securities law matters, including public and private financings, advice regarding disclosure issues and securities law compliance and fiduciary issues. Previously, he served as the firm's business department chair and chair of the firm's life sciences practice.

Robert is one of the country's leading practitioners for the representation of biotechnology companies. He is particularly well known for his work in the field of licensing and corporate partnering transactions. His biotechnology clients include, by way of example, Otsuka Pharmaceuticals, Portola Pharmaceuticals, Rigel Pharmaceuticals, Cytokinetics, Five Prime Therapeutics, Exelixis, Gilead Sciences and Onyx Pharmaceuticals.

Robert has been recognized by Chambers USA as a leading lawyer in California and nationwide for 19 years and has been recognized as a Northern California Super Lawyer since 2004.

In 1979, Robert received a JD degree from Stanford Law School, where he was elected to Order of the Coif, and an MBA degree from Stanford Graduate School of Business, where he received the Henry Ford II Scholar award for highest academic achievement. He also served as managing editor of the Stanford Journal of International Studies. Robert received a BA degree in 1975 from Swarthmore College, with a major in Economics.

Robert previously served as an instructor of Management at the Stanford Graduate School of Business, where he taught the course in Social and Ethical Issues in the Pharmaceutical and Biotechnology Industries.